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ABSTRACT
Introduction: Cholecystectomy is one of the most
common general surgical operations performed.
Despite level one evidence supporting the role of
cholecystectomy in the management of specific
gallbladder diseases, practice varies between surgeons
and hospitals. It is unknown whether these variations
account for the differences in surgical outcomes seen in
population-level retrospective data sets. This study aims
to investigate surgical outcomes following acute,
elective and delayed cholecystectomies in a multicentre,
contemporary, prospective, population-based cohort.
Methods and analysis: UK and Irish hospitals
performing cholecystectomies will be recruited utilising
trainee-led research collaboratives. Two months of
consecutive, adult patient data will be included.
The primary outcome measure of all-cause 30-day
readmission rate will be used in this study. Thirty-day
complication rates, bile leak rate, common bile duct
injury, conversion to open surgery, duration of surgery
and length of stay will be measured as secondary
outcomes. Prospective data on over 8000 procedures is
anticipated. Individual hospitals will be surveyed to
determine local policies and service provision.
Variations in outcomes will be investigated using
regression modelling to adjust for confounders.
Ethics and dissemination: Research ethics approval
is not required for this study and has been confirmed by
the online National Research Ethics Service (NRES)
decision tool. This novel study will investigate how
hospital-level surgical provision can affect patient
outcomes, using a cross-sectional methodology. The
results are essential to inform commissioning groups
and implement changes within the National Health
Service (NHS). Dissemination of the study protocol is
primarily through the trainee-led research collaboratives
and the Association of Upper Gastrointestinal Surgeons
(AUGIS). Individual centres will have access to their
own results and the collective results of the study will
be published in peer-reviewed journals and presented at
relevant surgical conferences.
INTRODUCTION
Cholecystectomy is one of the most com-
monly performed general surgical proce-
dures in the UK. Approximately 66 000
cholecystectomies were performed during the
2011–2012 ﬁnancial year in England alone.1
The pathway for these patients can be divided
into three distinct groups: (1) acute admis-
sion with biliary disease and the cholecystec-
tomy performed during that acute admission
(acute group); (2) planned elective admis-
sion for cholecystectomy referred by their
family doctor and added to the routine surgi-
cal waiting list from the outpatient depart-
ment only (elective group) and (3) all other
planned cholecystectomies performed on an
elective operating list, who have had a previ-
ous emergency surgical admission with
gallbladder (GB)-related disease (delayed
group). This is shown in ﬁgure 1.
The management of GB disease and
whether patients have acute, elective or
delayed operations varies widely between sur-
geons and hospitals.2–4 Level one evidence
Strengths and limitations of this study
▪ A multicentre, prospective study, with independent
validation of data.
▪ Capture of practice throughout the UK and Ireland.
▪ Data from all sizes of hospital and levels
of specialist services.
▪ Inability to assess postoperative visits to general
and family practitioners.
▪ Unable to capture the patients representing
to other hospitals.
▪ Complications after 30 days not collected.
▪ Reason for acute surgery decision may not be
fully elucidated.
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supports the role and safety of early or acute laparoscopic
cholecystectomy in biliary colic, cholecystitis and gall-
stone pancreatitis.5–10 Population-level data from
Hospital Episodes Statistics (HES) and a retrospective
study from Scotland, both suggest however, that early or
acute operations may be associated with poor surgical
outcomes.2 3 These studies also suggest that differences
in outcomes may be linked to hospital size and volume.2 3
Different surgical outcomes are commonly used to
measure quality of healthcare, such as readmissions, reo-
perations and mortality. In particular, reducing hospital
readmissions following surgery can lower hospital costs
and improve patient satisfaction.11 The causes of readmis-
sion after cholecystectomy have been poorly studied, but
are likely to vary by hospital size, case volume and
whether patients have acute, elective or delayed opera-
tions performed.12
Taken together, this raises the possibility that trial evi-
dence of common surgical procedures is not generalis-
able to population level, non-trial cohorts. Furthermore,
differences in patient outcomes may be linked to hos-
pital service provision. These factors both have an
important impact on patients and the National Health
Service (NHS), especially as trial data is in part used to
inform commissioning decisions. It is not clear currently,
why such variations occur in the NHS, or what the
impact of these variations is on surgical outcomes.
METHODS AND ANALYSIS
Primary aim
To measure the difference in all-cause 30-day readmis-
sions following acute, delayed and elective cholecystecto-
mies in a contemporary, population-based cohort.
Hypothesis
The 30-day readmission rate, following risk adjustment,
should be equivalent in patients following elective chole-
cystectomies compared with acute and delayed procedures.
Study design
We plan to undertake a multicentre, contemporary,
prospective, cohort audit which will be conducted
through trainee-led research collaboratives as described
previously.13
Setting
This study can take place in any UK or Irish hospital per-
forming acute, elective or delayed cholecystectomies.
Each centre will contribute 2 months of consecutive
patient data.
Participants
Inclusion criteria: All patients over the age of 18 years who
are undergoing a cholecystectomy can be entered into
this audit.
Exclusion criteria: Patients having a cholecystectomy for
known GB cancer, or as a part of another surgical pro-
cedure for example, Whipple’s procedure, bariatric, anti-
reﬂux or transplant operations, will be excluded.
Outcome measures
The primary outcome measure is all-cause 30-day readmis-
sion rate, which is deﬁned as any admission following dis-
charge which requires an overnight stay. This standard and
deﬁnition is based on the Royal College of Surgeons
(RCS) and the Association of Upper Gastrointestinal
Surgeons (AUGIS) of Great Britain and Ireland guidance
Figure 1 The pathway for
patients who undergo
cholecystectomy. Three groups of
patients will be assessed: (1)
acute admission with biliary
disease and the cholecystectomy
performed during that acute
admission (acute group); (2)
planned elective admission for
cholecystectomy referred by their
family doctor and added to the
routine surgical waiting list from
the outpatient department only
(elective group) and (3) all other
planned cholecystectomies
performed on an elective
operating list, who have had a
previous emergency surgical
admission with gallbladder-related
disease (delayed group).
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which states that the audit standard of less than 10%
30-day readmission rate should be reached by hospitals
performing cholecystectomies.4 Secondary outcome mea-
sures are listed in table 1.
Data collection
Data will be collected in a standardised Microsoft Excel
spreadsheet. It will be the responsibility of the local inves-
tigators to ensure that the data is password protected and
held on local trust computer systems. Each trust/hospital
site will need to identify locations where laparoscopic
cholecystectomy are performed (main theatre, day-case
unit, treatment centre) to ensure full capture of cases
during the audit period. Patients will be identiﬁed on a
daily basis from the elective operating lists and by on-call
teams, at handovers, from on-call lists and from emer-
gency theatre booking lists and logbooks. Operative data
should be completed either by or with input from the
operating surgeon or the assistant. All patients will be fol-
lowed for 30 days following their operation. The hospi-
tal’s electronic or paper records should be checked by
the team to identify any readmissions or reattendances to
the hospital’s emergency department, surgical assess-
ment unit or wards. Local arrangements may include:
▸ Reviewing the patient or patient’s notes during admis-
sion to identify inpatient complications.
▸ Check the discharge summary or letter to check for
any postoperative complications.
▸ Check for any outpatient attendances within 30 days
of surgery.
▸ Check electronic or paper hospital records or handover
lists for reattendances or readmissions. Check for any
accident and emergency department reattendances.
▸ Review imaging reports or laboratory results to check
for unplanned attendances which may have occurred.
Data validation and management
Following data collection, only data sets with >95% data
completeness will be accepted for pooled national ana-
lysis. The consultant surgeon principle investigator (PI)
at selected sites will identify an independent assessor to
validate all data points, with a target of >98% accuracy.
Overall, at least 5% of the data set will be independently
validated. In addition, the independent assessor will be
asked to examine operating theatre logbooks and trust
data systems, to ensure case ascertainment. If the con-
cordance between the total number of cases submitted
to the trial management group is <95%, the hospital’s
data will be removed from the analysis.
A standardised Microsoft Excel spreadsheet (Excel
2007; Microsoft, Redmond, Washington, USA) with
preset ﬁelds will be used to collect the data. Data protec-
tion regulations at each centre will be complied with.
Patient identiﬁable data will not be transmitted to the
trial management group. Data will be submitted centrally
via a secure NHS email address with all patient identiﬁers
removed. Patient anonymised data will be then be ana-
lysed and reported by the writing committee. Outcome
data speciﬁc to each individual surgeon who participates
will not be collected. Anonymised hospital data will be
Table 1 Secondary outcome measures
Outcome measure Definition
30 day all-cause postoperative
complications
As described by the Clavien-Dindo classification of postoperative complications.15
Specifically bile leak, CBD injury, wound infection, intra-abdominal collection,
pancreatitis, CBD stones, ICU/HDU readmissions will be collected, as will non-surgical
complications such as cardiac, respiratory, urinary and other 30 day complications
Bile leak Graded: A—bile leak which requires little or no change in the patients management,
resolves with conservative management within 7 days; B—bile leak or collection which
requires additional diagnostic or interventional procedures, such as ERCP or
relaparoscopy or Grade A which lasts >7 days; C—bile leak or collection which requires
relaparotomy16
Bile duct injury Any injury to the main biliary tree and will be classified using the Stewart-Way
Classification System17:
1. Defined as incomplete injury to the CBD with no loss of duct
2. Defined as lateral damage to the CHD with either stricture formation or fistula (bile
leak)
3. Defined as transection of the CBD with excision of a variable portion of the CBD and
cystic duct/common duct junction
4. Defined as injury to the right hepatic duct with or without injury to the right hepatic
artery
Conversion of operation Laparoscopic approach converted to an
open incision operation, or in which an abdominal incision to assist the procedure was
needed
Duration of surgery Time in minutes from skin incision to the end of skin closure
Length of stay Calculated from date of admission to date of discharge
CBD, common bile duct; CHD, common hepatic duct; ERCP, endoscopic retrograde cholangiopancreatography; HDU, high dependency unit;
ICU, intensive care unit.
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Table 2 Data fields
Field Options (definitions)
Age In years
Gender Male, female
Body mass index Individual’s body mass will be subclassified as:
▸ Underweight (<17.9 kg/m2)
▸ Normal (18.0–24.9 kg/m2)
▸ Overweight (25.0–29.9 kg/m2)
▸ Moderate obesity (30.0–34.9 kg/m2)
▸ Severe obesity (35.0–39.9 kg/m2)
▸ Very severe obesity (>40.0 kg/m2)
ASA score Classified as:
1. A normal healthy patient
2. A patient with mild systemic disease
3. A patient with severe systemic disease
4. A patient with severe systemic disease that is a constant threat to life
5. A moribund patient who is not expected to survive without the operation
Admission date Day/month/year
Operation date Day/month/year
Timing of surgery Classified as: acute; elective or delayed elective
Planned day-case Yes (defined as patients who are planned to be admitted and discharged on the
same day as the operation)
Date decision made to operate For ‘elective’ cases this will be the date the patient was seen in the outpatient
clinic. For ‘delayed’ cases this is the date the patient was last discharged from
hospital with biliary disease. For ‘acute’ cases this should be the date the
decision was made to perform an acute cholecystectomy in that emergency
admission
Preoperative indication Biliary colic (the presence of colicky right upper quadrant pain associated with
gallstones or sludge on an USS, but no signs of acute cholecystitis)
Acute or chronic cholecystitis current or previous clinical or ultrasound evidence
of cholecystitis (thick-walled GB and/or pericholecystitis, USS tenderness over
the GB, the presence of gallstones)
Gallstone pancreatitis (pancreatitis secondary to gallstones. Should be
diagnosed using the Atlanta guidelines which state the diagnosis of acute
pancreatitis requires two of the following three features: (1) abdominal pain
consistent with acute pancreatitis (acute onset of a persistent, severe, epigastric
pain often radiating to the back); (2) serum lipase activity (or amylase activity) at
least three times greater than the upper limit of normal; and (3) characteristic
findings of acute pancreatitis on contrast-enhanced CT)18
CBD stones (as confirmed by preoperative imaging, that may or may not have
been removed preoperatively)
GB polyps (hyperechoic lesions on USS imaging which have no acoustic
shadowing and do not move with positional changes (and have no features of
overt malignancy))
Dyskinesia (biliary-like abdominal pain, occurring in a normal appearing GB
with a functional HIDA scan showing an abnormal GB ejection fraction of less
than 40%)
Acalculous cholecystitis (clinical or ultrasound evidence (thick-walled GB and/or
pericholecystitis, USS tenderness over the GB, the absence of gallstones))
Surgical admissions with biliary symptoms
in the previous 12 months
Number of surgical admissions with biliary symptoms in the previous
12 months: 0, 1, 2, 3, 4, 5, >6
Total number of days spent in hospital as a result
Date of last discharge (if applicable)
Investigations ▸ USS
▸ CT
▸ MR cholangiopancreatography
▸ Endoscopic retrograde cholangiopancreatography
▸ Endoscopic USS
▸ Functional scan
Continued
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compared; individual surgeons, hospitals or NHS Trusts
will not be identiﬁed. The required anonymous data
ﬁelds are shown in table 2. Individual centres will be sur-
veyed at the end of the audit period to determine local
policies and service provision (table 3). Anonymous
patient-level data will be linked to the results of the hos-
pital service survey to allow detailed analysis of these vari-
ables and patient outcome.
Anticipated recruitment
On the basis of cholecystectomy-speciﬁc HES data
from England, 66 000 procedures were coded during
the 2011–2012 ﬁnancial year.1 If there is a uniform
distribution of procedures performed between each of
the acute care trusts and all hospitals in the UK and
Ireland participate, data on 11 000 procedures could be
potentially gathered prospectively. Minimum expected
recruitment would be approximately 1500 procedures
from 20 centres from the West Midlands.
Study timeline
Data collection and analysis will be performed using the
following timelines:
▸ 4 November 2013–11 December 2013—Pilot study
period.
▸ 1 March 2014–1 May 2014—Main study data collec-
tion period.
▸ 1 June 2014—Main study 30-day follow-up period ends.
Table 2 Continued
Field Options (definitions)
Seniority of surgeons ▸ <Specialty trainee (ST6)
▸ ST6 or above or staff grade
▸ Consultant
Perioperative antibiotics Yes/no
Method of operation ▸ Laparoscopic
▸ Laparoscopic converted to open
▸ Open cholecystectomy
▸ SILS
Degree of difficulty Nassar scale of difficulty for cholecystectomy graded 1, 2, 3, 419
Grade I Floppy, non-adherent gallbladder. Clear, thin cystic pedicle. Simple
adhesions to neck and Hartmann’s pouch only
Grade II Mucocele; packed with stones gallbladder. Fat-laden cystic pedicle.
Simple adhesions, up to the body of gallbladder
Grade III Deep fossa; acute cholecystitis; contracted, fibrous
Hartmann’s pouch adherent to CBD or with stone impaction.
Abnormal anatomy; cystic duct short, dilated or obscured.
Dense adhesions, up to the fundus; involving hepatic flexure or duodenum
Grade IV Completely obscured gallbladder; empyema/gangrene
Or mass. Impossible to clarify cystic pedicle. Dense, fibrous adhesions
wrapping the GB. Duodenum or hepatic flexure difficult to separate
Intraoperative complications ▸ Bile spilt (intra-abdominal spillage of bile during the procedure, including
when removing the GB from the abdominal cavity)
▸ Stones spilt (intra-abdominal spillage of stones during the procedure,
including as removing the GB from the abdominal cavity)
▸ Bleeding (requiring haemostatic agents (eg, Surgicel, Fibrillar, etc), extra
clips, suturing or conversion to open procedure)
▸ CBD injury (will be defined as any injury to the main biliary tree and will be
classified using the Stewart-Way Classification System (1, 2, 3, 4))
Intraoperative cholangiography ▸ Planned (defined as the decision to perform a cholangiogram before the
operation starts; eg, due to surgeon preference or to assess for CBD stones)
▸ Unplanned (defined as any other reason where a cholangiogram was
performed but was not anticipated at the start of the operation; eg, to assess
for unclear anatomy or to assess for potential CBD injury)
CBD exploration Yes/no
Abdominal drain Yes/no
Date of discharge Day/month/year
All-cause 30-day A&E attendance Yes/no
All 30-day reinterventions and reimaging Yes/no
30-day mortality Yes/no
A&E, accident and emergency department; ASA, American Society of Anesthesiologist; CBD, common bile duct; GB, gallbladder;
HIDA, hepatobiliary iminodiacetic acid; SILS, single-incision laparoscopic surgery; USS, ultrasound scan.
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▸ 31 August 2014—Central data submission anticipated
being complete.
▸ 20 December 2014—Independent data validation
anticipated being complete.
▸ 28 February 2015—Initial data analysis anticipated
being complete.
Statistical analysis
The report of this study will be prepared in accordance
to guidelines set by the STROBE (Strengthening the
Reporting of Observational Studies in Epidemiology)
statement for observational studies.14 Data will be col-
lected and analysed in clinically relevant categories, and
χ2 tests used to detect differences between groups.
Missing data will be analysed and multiple imputation
used if required.
Binary logistic regression modelling will be used to
adjust the inﬂuence of timing of surgery for key confound-
ing variables. Data will be adjusted for patient (age,
gender, American Society of Anesthesiologist (ASA) score
and body mass index), disease (indication, ultrasound
scan ﬁndings, the need of other imaging and endoscopic
retrograde cholangiopancreatography (ERCP)), surgeon
(consultant present, specialty and number of surgeons
performing cholecystectomy) and hospital (number of
hospital beds, university hospital, tertiary hepato-
pancreato-biliary services, acute admissions, ERCP services
and ‘Hot’ GB lists) factors. Multivariate models will be
built to produce ORs to account for the impact of predict-
ive variables when assessing outcomes. The OR represents
the odds of all-cause 30-day readmission occurring, com-
paring the experimental groups (acute and delayed)
versus the reference group (elective). A second model will
compare acute cholecystectomy against a reference of
delayed cholecystectomy. Variable selection including
hospital-level data will be based on those which are statistic-
ally signiﬁcant at univariate analysis, and those which are
clinically signiﬁcant, but not statistically. Depending on
data requirements, models will be developed using
ﬁxed-entry binary logistic regression, multilevel modelling
and multiply imputed data sets, to compare outputs based
on statistical technique.
The main strength of this project is the multicentre,
prospective, contemporary methodology with independ-
ent validation of the data. This will give high quality, vali-
dated data on cholecystectomy provision and outcome
throughout the UK and Ireland from a wide range of
hospital types.
Limitations include the inability to assess postoperative
visits to the general practitioner. In addition, a minority
of patients will re-present to other hospitals with compli-
cations following surgery. However, during the audit
Table 3 Hospital-level variables
Field Option (definition)
Location England; Scotland; Wales; Northern Ireland;
Republic of Ireland
University hospital Yes/no
Total number of beds <100; 100–500; 500–1000; >1000
Tertiary HPB services Yes/no
ERCP services Yes/no
Acute admissions Yes/no
Number of consultants on the general surgery on-call rota Number
Consultant specialties involved in performing cholecystectomies Oesophagogastric
Hepatobiliary
Colorectal
Breast
Vascular
Endocrine
General
Transplant
Other
Number of consultant surgeons offering cholecystectomy Number
Number of consultant surgeons offering acute/emergency cholecystectomy Number
Number of consultant surgeons offering laparoscopic CBD exploration Number
Does your hospital offer dedicated ‘hot’ gallbladder theatre lists Yes/no
Performing an intraoperative cholangiography Yes/no
Additional hospital services available MRCP
Endoscopic USS
Functional scans
Radiological drainage
Percutaneous transhepatic cholangiograms
Radiological cholecystostomy
CBD, common bile duct; ERCP, endoscopic retrograde cholangiopancreatography; HPB, hepato-pancreato-biliary; MRCP, MR
cholangiopancreatography; USS, ultrasound scan.
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period, teams will also document the absolute number
of patients readmitted with complications from chole-
cystectomy performed at other hospitals. Our study uses
the standard 30 day follow-up period as this is the inter-
national standard and allows comparison with other
studies. However, complications which may occur after
30 days, such as retained common bile duct stones or
late biliary strictures will not be reported. In the acute
group, it may not be possible to fully elucidate whether
the decision to operate was due to hospital policies,
surgeon preference or patient-related factors. However,
we will collect data on patient, disease, surgeon and hos-
pital factors to assess which is associated with acute
cholecystectomy.
DISCUSSION
Variations in outcomes following common surgical proce-
dures such as cholecystectomy are a concern for the
NHS. This paper describes the protocol for a novel study
to investigate how hospital-level surgical provision can
affect patient outcomes using cross-sectional method-
ology. The results of this audit are essential to inform
commissioning groups and implement changes within
the NHS. Furthermore, the development of consultant
PIs across the UK enables a network of new investigators
who can be approached to collaborate on further studies.
ETHICS AND DISSEMINATION
The proposed study will not affect clinical care and com-
pares an outcome to a deﬁned audit standard. Research
ethics approval is not required for this study and this has
been conﬁrmed by the use of the online National
Research Ethics Service (NRES) decision tool (http://
www.hra-decisiontools.org.uk/research/). This has been
further supported by written conﬁrmation and
advice from the Research and Development Director at
University Hospitals Birmingham NHS Foundation
Trust, UK. The study will be registered as a clinical audit
or service evaluation at each participating hospital.
Patient consent is not deemed necessary and inclusion
in the study will not incur any risk to individual patients.
The generic collaborative methodology underlying
protocol dissemination and collaborator recruitment
has been described previously.13 The protocol will be
disseminated primarily through the trainee-led
research collaboratives (http://www.asit.org/resources/
collaboratives), and members of the Association of
Surgeons in Training (ASIT; http://www.asit.org), AUGIS
(http://www.augist.org) and the Schoolofsurgery.org
(http://www.schoolofsurgery.org). A consultant surgeon
PI will be designated at each hospital to facilitate coordin-
ation of the study. The protocol document and data collec-
tion tools will be made available online (http://www.
choles-study.org). Individual centres will have access to
their own results and the collective results of the study will
be published in peer-reviewed journals and presented at
relevant surgical conferences. These results can then be
used to inform commissioning and implement changes
within the NHS.
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